Covaxin trials on children expected to start in June: Bharat Biotech
Bharat Biotech, the creator of Covid illness immunization Covaxin, is required to begin pediatric preliminaries from June, the organization's Business Development and International Advocacy Head Dr. Raches Ella on Sunday.
"We focused on developing the product last year. Now our focus is on ramping up our manufacturing capacity. Kids vaccine trials of Bharath Biotech may get the license in the third quarter of this year," Dr. Ella said during a virtual conversation with members of FICCI Ladies Organisation (FLO), Hyderabad.
Reacting to an inquiry from one of the members, Dr. Ella said that Bharat Biotech will increase the assembling limit of Covaxin to 700 million portions before the current year's over.
"We are happy to have the full support of the government because of which we are able to stand where we are today in this journey. The vaccine is co-developed by us and ICMR. The government placed an advanced purchase order of ₹1,500 crores. This will help us to increase our risk appetite. That is why we are expanding to Bangalore and Gujarat," he added.
Srinagar: due to the result of the Post-Civilian killings and in the days running up regarding the visit of Union Minister Amit Shah in Srinagar durin...
Mumbai: NCB officer was asked whether he would take any legal action against the NCP leader Nawab Malik. And the allegations that were made by him, th...